-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
USDBörse NYSE New York Stock Exchange
Mitarbeiter
67.000
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von
Dir gefallen die Informationen zu Merck & Co., Inc.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Merck & Co., Inc.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Merck & Co., Inc.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Merck & Co., Inc.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
149 News & Informationen zur Merck & Co., Inc. Aktie
Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DUBLIN, Ireland, July 09, 2021 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc NBRV, a biopharmaceutical company engaged in the commercialization and development
Mid-Morning Market Update: Markets Open Higher; AZZ Reports Upbeat Q1 Results
Following the market opening Friday, the Dow traded up 1.10% to 34,799.54 while the NASDAQ rose 0.63% to 14,651.61. The S&P also rose, gaining 0.84% to …
Active Pharmaceutical Ingredients Market Worth USD 312 Billion by 2028 at 6.2% CAGR – Report by Market Research Future (MRFR)
Active Pharmaceutical Ingredients Market Insights and Industry Analysis by Type of Synthesis (Biotech and Synthetic), By Molecules (Large Molecule and…
Global Stress Management Market Size to Grow at a CAGR of 3.5% from 2021 to 2030
The global stress management market reached USD 18,600.9 million in 2020 and is projected to grow at a CAGR of 3.5% during the forecast period. Based on…
Molnupiravir shows fewer hospital admissions, faster clinical improvement in phase 3 trials: Hetero
Company applied to DCGI for Emergency Use Authorisation
Hikari Power Ltd Buys AbbVie Inc, Merck Inc, Vanguard Health Care ETF, Sells Wells Fargo, Nutrien, Cisco Systems Inc
GuruFocus Article or News written by insider and the topic is about:
Danger Lurks for These 2 High-Yield Dividend Stocks
Investors shouldn't get too comfortable with these yields.
Integral Ad Science Announces New Appointments To Board Of Directors
NEW YORK, July 8, 2021 /PRNewswire/ — Integral Ad Science IAS, a global leader in digital media quality, today announced that Bridgette Heller, co-founder &
Top Penny Stocks to for Your Buy List Right Now? Here’s 9 to Watch
Mid-Afternoon Market Update: Dow Rises 70 Points; IDEAYA Biosciences Shares Slide
Toward the end of trading Wednesday, the Dow traded up 0.20% to 34,647.52 while the NASDAQ rose 0.01% to 14,664.04. The S&P also rose, gaining 0.33% to …
Global Anticoagulants Market (2021 to 2026) – by Drug Class, Route of Administration and Geography
DUBLIN, July 7, 2021 /PRNewswire/ — The 'Global Anticoagulants Market (2021-2026) by Drug Class, Route of Administration, Geography and the Impac…
Outlook On The Pulmonary Drugs Global Market To 2026 – Rising Prevalence Of Pulmonary Diseases Is Driving Growth
DUBLIN, July 7, 2021 /PRNewswire/ — The “Global Pulmonary Drugs Market (2021-2026) by Drug Class, Indication, Distribution Channel, Geography, Competitive
Hot Small-Cap Stocks To Watch With Potential Cancer Breakthroughs
The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ju…
Armata Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare Conference
/PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on pathogen-specific…
4D Pharma Announces Publication Of Preclinical Research Showing Single Strain Megasphaera Massiliensis Improves Activity Of CAR-T
4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived
Merck : FDA Approves Expanded Indication for Merck's KEYTRUDA® (pembrolizumab) in Locally Advanced Cutaneous Squamous Cell Carcinoma (cSCC)
KEYTRUDA Is Now Approved for the Treatment of Patients With Recurrent or Metastatic or Locally Advanced cSCC That Is Not Curable by Surgery or Radiation
… | July 6, 2021
FDA Approves Expanded Indication For Merck's KEYTRUDA® (pembrolizumab) In Locally Advanced Cutaneous Squamous Cell Carcinoma (cSCC)
Merck MRK, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label
Bionomics Initiates Phase 2b ATTUNE Study Of BNC210 In PTSD
ADELAIDE, Australia, July 6, 2021 /PRNewswire/ — Bionomics Limited (ASX: BNO, OTCQB:BNOEF) ( Bionomics or Company), a global, clinical stage biopharmaceutical
Neurodegenerative Disease, Cancer Stocks Among Top Biotech Gainers In 2021
Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) advancing …
Merck (MRK) to Withdraw a Gastric Cancer Indication for Keytruda
Merck's (MRK) Keytruda is approved under FDA's accelerated pathway for recurrent gastric or gastroesophageal junction adenocarcinoma indication but fails in post-marketing commitment study.
Antibiotics Market Size Worth USD 64,532 Million by 2025 at 4.8% CAGR – Report by Market Research Future (MRFR)
Antibiotics Market Insights and Industry Analysis by Spectrum of Activity (Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic), Drug Class…
Merck’s new CEO Robert Davis begins, after Ken Frazier's retirement
Robert Davis became the new chief executive officer of Merck on Thursday, one day after former CEO Ken Frazier retired.
Alpine (ALPN) Enters Immuno-Oncology Collaboration With Merck
Alpine (ALPN) signs a collaboration and supply deal with Merck to evaluate ALPN-202 in combination with the latter's Keytruda for treating various types of cancer.
Best Penny Stocks For Your July 2021 List? 8 Biotechs To Watch Now
Cytovation Announces Clinical Collaboration With MSD To Evaluate Its First-in-class Tumorolytic Agent CyPep-1 In Combination With KEYTRUDA®
BERGEN, Norway, July 30, 2021 /PRNewswire/ — Cytovation AS, a clinical stage immune-oncology company focused on the development of its first-in-class
Corning Appoints Pamela J. Craig to its Board of Directors
CORNING, N.Y., June 29, 2021 (GLOBE NEWSWIRE) — Corning Incorporated (NYSE:GLW) today announced that Pamela J. Craig, former chief financial officer of…
Price Over Earnings Overview: Merck & Co
In the current session, Merck & Co Inc. (NYSE:MRK) is trading at $76.99, after a 0.17% increase. Over the past month, the stock increased …
EC Oks Merck's Keytruda Plus Chemotherapy For Treatment Of Certain Patients With Esophageal Cancer
(RTTNews) – The European Commission has approved Keytruda, Merck & Co Inc.'s (MRK) anti-PD-1 therapy, in combination with platinum- and fluoropyri…
Renovacor Announces the Appointments of Joan Lau, Ph.D., and Gregory F. Covino to its Board of Directors
PHILADELPHIA, June 29, 2021 — Renovacor, Inc. , an early‑stage biotechnology company developing adeno-associated virus ‑based gene therapies for devastating cardiovascular and…
4D Pharma To Participate In Ladenburg Thalmann Healthcare Conference
4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived
Renovacor Announces the Appointments of Joan Lau, Ph.D., and Gregory F. Covino to its Board of Directors
Appointments to be effective upon closing of the previously announced merger between Renovacor and Chardan Healthcare Acquisition 2 Corp….
Lexington Business News – July 2021
Intellia Shares Soar on Positive Test Results
GuruFocus Article or News written by Barry Cohen and the topic is about: Merck, Sanofi, Gilead and others stand to benefit from clinical trials
Merck Desperate To Get Back In Coronavirus Race, With A Pill (NYSE:MRK)
Competitors beating Merck for COVID-19 treatment. Proof of Molunupiravir efficacy is elusive. A successful pill for COVID could add significant revenue. Read more here…
Global Respiratory Inhalers Market to Reach $48.7 Billion by 2026
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
High Touch Investor Relations : Joins Council for Inclusive Capitalism
Council Members Announce Measurable Actions Their Organizations Are Taking To Create a More Inclusive Economy …
Forget Dogecoin: These Dogs of the Dow Are More Likely to Make You Rich
If you've been bitten by the shiba inu, try investing in the type of dog that pays.
How Will the Drop in Biogen’s Share Price Hit Buffett’s Portfolio? – 24
One of six drugmakers in Berkshire Hathaway's portfolio, dropped by more than 6% on Thursday, but it remains the best performer of the six investments.
Active Pharmaceutical Ingredient Market Revenue To Reach ~$300 Billion by 2030: P&S Intelligence
/PRNewswire/ — The global active pharmaceutical ingredient (API) market is set for rapid expansion in the coming years, primarily because of the increasing…